Natco's biosimilars entry plan lifts stock
This article was originally published in Scrip
Executive Summary
Shares of Natco Pharma spurted on Indian bourses after the company announced plans to enter the biosimilars segment, via an exclusive pact with Chemo Sa Lugano of Switzerland.